Vyome Holdings (HIND) Exchange Rate Effect (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Exchange Rate Effect of -$39454.0 for Q1 2026, down 3945500.0% year-over-year from N/an in Q1 2025, and down 275.72% quarter-over-quarter from -$10501.0 in Q4 2025.
Vyome Holdings (HIND) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Vyome Holdings' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$39454.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 3945500.0% year-over-year to -$39454.0; the TTM figure through Mar 2026 stood at -$65149.0 (down 813.73% YoY), while the FY2025 annual figure was -$25694.0, down 2379.86% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$39454.0, down from -$10501.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $21000.0 in Q1 2022, with the low at -$39454.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is -$1000.0 (2022), against an average of -$4401.4.
- The sharpest annual moves came in 2024 and 2026: Exchange Rate Effect jumped 800.0% in 2024, then sank 3945500.0% in 2026.
- Vyome Holdings' Exchange Rate Effect stood at -$20000.0 in 2022, then jumped by 95.0% to -$1000.0 in 2023, then surged by 206.7% to $1067.0 in 2024, then slumped by 1084.16% to -$10501.0 in 2025, then plunged by 275.72% to -$39454.0 in 2026.
- Business Quant data shows HIND's Exchange Rate Effect at -$39454.0 in Q1 2026, -$10501.0 in Q4 2025, and -$10193.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -1,561.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,561.00 |
| Jun 30, 2026 | -1,561.00 |
| Mar 31, 2026 | -39,454.00 |
| Mar 31, 2026 | -39,454.00 |
| Dec 31, 2025 | -10,501.00 |
| Dec 31, 2025 | -10,501.00 |
| Sep 30, 2025 | -10,193.00 |
| Sep 30, 2025 | -10,193.00 |
| Jun 30, 2025 | -5,001.00 |
| Jun 30, 2025 | -5,001.00 |
| Mar 31, 2025 | 1.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 1,067.00 |
| Dec 31, 2024 | 1,067.00 |
| Sep 30, 2024 | 1,060.00 |
| Sep 30, 2024 | 1,060.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |